Randomized Comparative study of Pancreatinum 6c & Insulinum 6c in DM type II patients aged 30 to 75 years
Not Applicable
- Conditions
- Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
- Registration Number
- CTRI/2024/04/065132
- Lead Sponsor
- Dr Sukumar J Magdum Foundation Jaysingpur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients taking Tab. Metformin orally for at least 3 months
Exclusion Criteria
1. Immune-compromised patients
2. Pregnant females
3. Patients taking subcutaneous Inj. Insulin for DM –II
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Blood Glucose Level if anyTimepoint: Base line and every monthly for 3 months
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI